Pharma

Your Article Summary

See Latest Articles

MediGene Signs Agreement with Solvay for the Commercialization of Veregen in Germany, Austria, and Switzerland
MediGene, 09/30/09

The biotech company MediGene AG has signed a license and supply agreement with Solvay Arzneimittel GmbH, the German affiliate of Solvay Pharmaceuticals for the supply and commercialization of Veregen in Germany, Austria, and Switzerland. Solvay's subsidiaries will promote and distribute the drug for the treatment of genital warts in the above–mentioned countries. In Switzerland Solvay will also take charge of the Veregen regulatory procedures.

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

Shire Reports Tolerability and Clinical Effects Results of DAYTRANA from Study in Adolescents with ADHD
Shire, 11/02/09

See All of Marketing/Media/ROI

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09

Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09

See All of Medical Devices/Products